Construction Of Recombinant Bcg Expressing The
Vp1 Antigen Of Enterovirus 71 For The Development
Of A Candidate Vaccine

QR Code

Construction Of Recombinant Bcg Expressing The Vp1 Antigen Of Enterovirus 71 For The Development Of A Candidate Vaccine

Enterovirus 71 (EV71), pencetus penyebab wabak penyakit tangan, kuku dan mulut (HMFD) di kalangan kanak-kanak telahpun dikenalpasti sebagai wabak yang diperlu dikawal segera Enterovirus 71 (EV71), the causativeing agent of outbreaks of hand, foot and mouth disease (HFMD) in children is identif...

Full description

Bibliographic Details
Main Author:	Othman, Nurulhasanah
Format:	Thesis
Language:	English
Published:	2006
Subjects:	Q Science
Online Access:	http://eprints.usm.my/29305/ http://eprints.usm.my/29305/1/Construction_of_recombinant_bcg_expressing_the_vp1_antigen.pdf

Similar Items

Construction Of Recombinant BCG Expressing The VP1 Antigen Of Enterovirus 71 For The Development Of A Candidate Vaccine [QR186.87. N974 2007 f rb]
by: Othman, Nurulhasanah
Published: (2006)

The expression of recombinant bacille calmette-guerin (rBCG) containing VPI gene of enterovirus 71 (EV71)
by: Wey, Goh Kai
Published: (2008)

Immunogenicity of soluble enterovirus 71 recombinant VP1 protein in mice model
by: Mustafa, Suhaili
Published: (2017)

Factors affecting expression and solubility of Enterovirus 71 VP1 protein
by: Ahmad Hafad, Fathimah Azzahroh
Published: (2016)

Immunogenicity study of dna vaccine and dna vaccine carrier expressing vp1 of enterovirus 71 in the prime boost vaccination strategy
by: Nur Ayuni, Kadir
Published: (2008)

Protective Efficacy Evaluation of NPt-NPt-VP1₁₋₁₀₀Protein as a Candidate Vaccine Against Enterovirus 71 Infections in Mouse Model
by: Ch'ng, Wei Choong
Published: (2010)

Impact of genetic changes, pathogenicity and antigenicity on Enterovirus- A71 vaccine development
by: Yee, Isabel Pin Tsin *, et al.
Published: (2017)

Partial protection against enterovirus 71 (EV71) infection in a mouse model immunized with recombinant newcastle disease virus capsids displaying the EV71 VP1 fragment.
by: Wei, Choong Ch'ng, et al.
Published: (2011)

The Nucleocapsid Protein Of Newcastle Disease Virus As A Carrier For The Vp1 Polypeptides Of Enterovirus 71
by: Sivasamugham, Lalita Ambigal
Published: (2005)

Inhibition of Enterovirus 71 (EV-71 infections by a novel antiviral peptide derived from EV-71 capsid protein VP1
by: Tan, Chee Wah, et al.
Published: (2012)

Development of novel vaccines against Enterovirus-71
by: Yee, Isabel Pin Tsin *, et al.
Published: (2015)

Development of antivirals and vaccines against enterovirus 71 (EV-A71)
by: Poh, Chit Laa *
Published: (2018)

Development of human enterovirus 71 nano calcium phosphate adjuvanted candidate vaccine for parenteral and mucosal delivery
by: Saeed Ahmed, Mohamed Ibrahim
Published: (2015)

Molecular Epidemiology of Human Enterovirus 71 Strains and Recent Outbreaks in the Asia-Pacific Region: Comparative Analysis of the VP1 and VP4 Genes
by: Cardosa, Mary Jane, et al.
Published: (2003)

Development of a Deoxyribonucleic Acid Vaccine Against Enterovirus 71
by: Wong, Siew Tung
Published: (2005)

Recombinant human enterovirus 71 in hand, foot and mouth disease patients
by: Yoke, Fun Chan, et al.
Published: (2004)

A comparison of the VP1, VP2, and VP4 regions for molecular typing of human enteroviruses
by: Perera, D., et al.
Published: (2010)

High-titred neutralizing antibodies to human enterovirus 71 preferentially bind to the N-terminal portion of the capsid protein VP1
by: Tan, Cheng Siang, et al.
Published: (2007)

Immunogenicity of recombinant mycobacterium smegmatis expressing antigen 85b epitopes as a potential tuberculosis vaccine candidate
by: Kadir , Nur Ayuni
Published: (2017)

The immunogenicity of recombinant vaccines based on modified Vaccinia Ankara (MVA) viruses expressing African horse sickness virus VP2 antigens depends on the levels of expressed VP2 protein delivered to the host
by: Calvo-Pinilla, Eva, et al.
Published: (2018)

T Cell immunity to enterovirus 71 infection in humans and implications for vaccine development
by: Yee, Isabel Pin Tsin *, et al.
Published: (2018)

Immunogenicity of a truncated enterovirus 71 VP1 protein fused to a Newcastle disease virus nucleocapsid protein fragment in mice.
by: Ch'ng, Wei Choong, et al.
Published: (2011)

Development of novel miRNA-based vaccines and antivirals against Enterovirus 71
by: Yee, Isabel Pin Tsin *, et al.
Published: (2016)

Pro inflammatory responses of thp-1 macrophage cell line infected with recombinant bcg (rBCG) expressing the MSP-1C of Plasmodium falciparum
by: Yen, Pong Sze
Published: (2013)

Identification of mimotopes of human enterovirus 71
by: Yee, Siew Fung.
Published: (2007)

Immunoregulatory effects of recombinant BCG (rBCG) expressing c-terminus of merozoite surface protein-1 (MSP-1C) of Plasmodium falciparum on mouse macrophage
by: Mohamad, Dhaniah
Published: (2013)

Detection of apoptosis in human macrophage cell line, THP-1 infected with BCG and recombinant BCG (rBCG) expressing the 19-kDa C-terminus of the Merozoite Surface Protein-1 (MSP-1C)
by: Mei, Cheong Siew
Published: (2013)

Flavonoids as antiviral agents for Enterovirus A71 (EV-A71)
by: Lalani, S.*, et al.
Published: (2020)

Proteoliposomes from mycobacterium bovis BCG and mycobacterium smegmatis as new vaccine candidates against tuberculosis
by: Kadir, Ramlah
Published: (2016)

Cloning of vacll into pnmn013: development of a recombinant bcg vaccine against tuberculosis
by: Ramli, Siti Nur Rasyidah Md
Published: (2004)

Clinical features, diagnosis, and management of enterovirus 71
by: Ooi, Mong How, et al.
Published: (2010)

Virology, epidemiology, pathogenesis, and control of enterovirus 71.
by: Solomon, Tom, et al.
Published: (2010)

A decade of sustained selection pressure on two surface sites of the VP1 protein of Enterovirus A71 suggests that immune evasion may be an indirect driver for virulence
by: Roberts, Ryan, et al.
Published: (2019)

The role of TLR-2 IN the production of TNF-a and IL-10 by macrophage infected with a recombinant BCG (rBCG) expressing the MSP-1COF Plasmodium falciparum
by: Rajendran, Sasirekha D/O
Published: (2015)

Development of recombinant Mycobacterium smegmatis (MS) expressing B- and T-cell epitopes of latency associated antigens of Mycobacterium tuberculosis (MTB) as a TB vaccine candidate
by: Ismail, Mohd Zakuan
Published: (2017)

Development of live attenuated Enterovirus 71 vaccine strains that confer protection against lethal challenge in mice
by: Yee, Isabel Pin Tsin *, et al.
Published: (2019)

Beta-actin variant is necessary for Enterovirus 71 replication
by: Lui, Edmund Yan Long, et al.
Published: (2013)

Impact of genetic changes in the Enterovirus 71 genome on virulence
by: Poh, Chit Laa *, et al.
Published: (2019)

Molecular Characterisation Of Infectious Bursal Disease Virus And Expression Of Vp2 Protein For The Development Of Diagnostic Kit And Recombinant Vaccine
by: Mat Isa, Nurulfiza
Published: (2008)

Rational design of live attenuated vaccine by site-directed mutagenesis and deletion in the 5’- non coding region of the enterovirus 71(EV-A71) genome
by: Yee, Isabel Pin Tsin *
Published: (2015)